Atropine successful in slowing down child myopia
Low-dose atropine (0.01%) is being prescribed to slow down the development of nearsightedness (myopia) in children of five to 15 years of age. Initial research papers about the treatment focused primarily on children of Asian heritage. It wasn’t long before children of other nationalities began using the mild drops with...